Surgery Partners, Inc. (NASDAQ:SGRY) Shares Acquired by BNP Paribas Financial Markets

BNP Paribas Financial Markets increased its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 54.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 315,083 shares of the company's stock after acquiring an additional 110,664 shares during the period. BNP Paribas Financial Markets owned about 0.25% of Surgery Partners worth $10,080,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Mesirow Institutional Investment Management Inc. grew its holdings in Surgery Partners by 12.4% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company's stock valued at $108,000 after purchasing an additional 373 shares during the period. Amalgamated Bank grew its holdings in Surgery Partners by 7.6% in the third quarter. Amalgamated Bank now owns 9,948 shares of the company's stock valued at $291,000 after purchasing an additional 701 shares during the period. Raymond James & Associates grew its holdings in Surgery Partners by 1.2% in the third quarter. Raymond James & Associates now owns 61,188 shares of the company's stock valued at $1,790,000 after purchasing an additional 736 shares during the period. Natixis Advisors L.P. grew its holdings in Surgery Partners by 8.6% in the fourth quarter. Natixis Advisors L.P. now owns 11,735 shares of the company's stock valued at $375,000 after purchasing an additional 934 shares during the period. Finally, Nisa Investment Advisors LLC boosted its stake in shares of Surgery Partners by 69.7% in the third quarter. Nisa Investment Advisors LLC now owns 2,945 shares of the company's stock worth $86,000 after acquiring an additional 1,210 shares during the last quarter.

Insider Activity

In related news, CEO Jason Eric Evans sold 1,984 shares of the stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $29.44, for a total transaction of $58,408.96. Following the transaction, the chief executive officer now owns 464,510 shares of the company's stock, valued at approximately $13,675,174.40. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.60% of the company's stock.

Surgery Partners Trading Down 2.3 %

NASDAQ SGRY traded down $0.62 on Friday, reaching $25.83. 781,405 shares of the company were exchanged, compared to its average volume of 934,270. The business's fifty day moving average price is $26.82 and its 200 day moving average price is $29.91. The stock has a market capitalization of $3.28 billion, a P/E ratio of 31.48, a price-to-earnings-growth ratio of 2.14 and a beta of 2.75. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 0.92. Surgery Partners, Inc. has a fifty-two week low of $22.05 and a fifty-two week high of $45.79.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Monday, February 26th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. Surgery Partners had a return on equity of 3.65% and a net margin of 0.02%. The business had revenue of $735.40 million for the quarter, compared to analyst estimates of $741.93 million. During the same quarter in the prior year, the company posted $0.22 EPS. The company's quarterly revenue was up 4.0% on a year-over-year basis. Analysts forecast that Surgery Partners, Inc. will post 0.84 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SGRY has been the subject of several research reports. StockNews.com upgraded Surgery Partners from a "sell" rating to a "hold" rating in a research report on Thursday, March 21st. Barclays initiated coverage on Surgery Partners in a research report on Wednesday, March 6th. They set an "equal weight" rating and a $35.00 price target for the company. Benchmark reiterated a "buy" rating and set a $50.00 price target on shares of Surgery Partners in a research report on Wednesday, May 1st. Cantor Fitzgerald reiterated an "overweight" rating and set a $43.00 price target on shares of Surgery Partners in a research report on Wednesday, April 10th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $49.00 price target on shares of Surgery Partners in a research report on Thursday, February 29th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and a consensus target price of $43.13.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.